最新ニュース CME Gr (NASDAQ:CME) 株価情報

CME Gr

Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies, energy, metals, and commodities. The Chicago Mercantile Exchange was founded in 1898 and in 2002 completed its IPO. Since then, CME Group has consolidated parts of the industry by merging with crosstown rival CBOT Holdings in 2007 before acquiring Nymex Holdings in 2008 and NEX in 2018. In addition, the company has a 27% stake in S&P Dow Jones Indices, making the Chicago Mercantile Exchange the exclusive venue to trade and clear S&P futures contracts. Through CME's acquisition of NEX, it also expanded into cash foreign exchange, fixed-income trading, and collateral optimization.

CME Group Inc

COMPUTER ENGNR&CONSLTNG by Computer Engineering & Consulting Ltd

Computer Engineering & Consulting Ltd

CHINA MEIDONG AUTO HLDGS by China Meidong Auto Hldgs

China MeiDong Auto Holdings Ltd

CM ENERGY TECH CO LTD by CM ENERGY TECH CO LTD

CM Energy Tech Co Ltd

CREO MED GROUP LTD by CREO MED GROUP LTD.

Creo Medical Group PLC

CoinMerge (BEP-20)

CMONEY INC by cMoney, Inc.

<a href="https://www.benzinga.com/topic/chicago-mercantile-exchange">Global derivatives marketplace</a> CME Group Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>) on Wednesday announced the upcoming launch of options on its Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) Friday futures contracts, pending regulatory approval.
These new contracts are set to be the first financially-settled cryptocurrency options offered by CME Group with daily expiries available Monday through Friday, aiming to provide traders greater flexibility for managing short-term Bitcoin price risk.
According to a <a href="https://www.prnewswire.com/news-releases/cme-group-to-launch-options-on-bitcoin-friday-futures-302363475.html">release</a>, the new options on Bitcoin Friday futures are designed to complement CME Group&#8217;s existing suite of physically-settled options on Bitcoin, Ether (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>), Micro Bitcoin and Micro Ether futures.
These new contracts are a tool for traders to manage short-term Bitcoin price risk with the smaller contract size and daily expiries.
Giovanni Vicioso, CME Group Global Head of Cryptocurrency Products said, &#8220;We are pleased to offer these new options that provide traders with even greater precision to manage short-term bitcoin price risk.&#8221; 
&#8220;Building on the success of our Bitcoin Friday futures, the smaller size of these contracts, along with daily expiries, offer market participants a capital-efficient toolset to effectively adjust their bitcoin exposure,&#8221; he added.
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/25/01/43314878/coinbase-taps-trumps-campaign-manager-chris-lacivita-to-tackle-crypto-policy-in-washington">Coinbase Taps Trump&#8217;s Campaign Manager, Chris LaCivita To Tackle Crypto Policy In Washington</a>
These contracts have been met with favorable opinions from those in the digital asset space. 
Joshua Lim, Global Co-head of Markets at FalconX said, &#8220;Given the increasing density of tradable catalysts in crypto, CME Group&#8217;s new option suite on Bitcoin Friday futures provides the granularity that market participants need for hedging and expressing nuanced views on Bitcoin.
Jason Urban, Global Head of Trading at Galaxy, noted that these contracts offer a flexible and cost-effective way for our trading desk to optimize risk management and provide tailored solutions to our counterparties navigating bitcoin price volatility.
The release also said that Bitcoin Friday futures have become CME Group&#8217;s most successful cryptocurrency product launch, with more than 775,000 contracts traded since its launch on September 29 and an average daily volume of 9,700 contracts. 44% of the contracts are traded during non-U.S. trading hours.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/01/43312600/trump-media-group-to-invest-in-bitcoin-financial-services">Trump Media Group To Invest In Bitcoin, Financial Services</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

News

$BTC

$ETH

CME Group Expands Crypto Offerings With Options On Bitcoin Friday Futures

CME Group, the world's leading derivatives marketplace, today announced it will introduce options on Bitcoin Friday futures on February 24, pending regulatory review.
These new contracts will be the first CME Group cryptocurrency options to be financially-settled, with expiries available every day of the business week, Monday through Friday.

Markets

CME Group Announces It Will Introduce Options On Bitcoin Friday Futures On February 24, Pending Regulatory Review.

<ul>
<li>CME Group introduces its first equity index, FX, cryptocurrency, metals and energy contracts to Robinhood customers</li>
</ul>

HOOD

CME Group Futures To Launch On Robinhood

CME Gr's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CME#NYSE">CME</a>) short percent of float has fallen 9.09% since its last report. The company recently reported that it has 4.32 million shares sold short, which is 1.2% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.5 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>CME Gr Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1737575121_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for CME Gr has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing CME Gr's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, CME Gr's peer group average for short interest as a percentage of float is 3.08%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Trading Ideas

(CME) - Analyzing CME Gr's Short Interest

Keefe, Bruyette &amp; Woods analyst Kyle Voigt maintains CME Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>) with a Market Perform and lowers the price target from $260 to $256.

Price Target

Analyst Ratings

Keefe, Bruyette & Woods Maintains Market Perform on CME Gr, Lowers Price Target to $256

&nbsp;CME Group, the world's leading derivatives marketplace, today announced that its international average daily volume (ADV) reached a record 7.8 million contracts in 2024, up 14% from 2023.&nbsp;Reflecting all trading reported outside the United States, this was driven by record growth in Energy up 31%, Metals up 27%, Agricultural up 25%, Interest Rate up 12% and Foreign Exchange products up 10% compared to the same period in 2023.

CME Group Hits Record 7.8 Million Daily International Contracts in 2024, up 14% YoY Driven by Energy and Metals Growth

A significant gap in the Chicago Mercantile Exchange (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>) Bitcoin futures contract near $75,000, suggests a <a href="https://www.benzinga.com/markets/cryptocurrency/25/01/42871814/bitcoin-slides-5-touches-95000-mark-why-is-btc-going-down">potential downside move</a> for Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) in the short-term, according to Joe McCann, founder of Asymmetric.
What Happened: McCann&#8217;s <a href="https://x.com/joemccann/status/1876803399854817562">analysis</a> from Tuesday paints a bearish picture, shifting away from previous bullish sentiments, as he notes a confluence of technical and macroeconomic indicators pointing toward a near-term price correction.
McCann highlighted several factors supporting his short-term bearish outlook, including technical patterns, market liquidity and broader economic conditions.
&#8220;The month of December printed a shooting star candle,&#8221; McCann noted, a technical signal that historically indicates bearish sentiment. 
&#8220;There is a massive gap to be filled in the CME Bitcoin futures product&#8230;down near $75,000,&#8221; he added.
According to McCann, Bitcoin&#8217;s recent price action has shown weakness, with Tuesday&#8217;s movement described as &#8220;a classic rejection beneath a multi-month regression channel.&#8221; 
He sought to highlight the significance of the 10-month moving average, which has historically acted as a pullback level during bull markets. 
&#8220;In this case, the 10 MA is right around&#8230;$75,000,&#8221; McCann stated.
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/25/01/42856923/cftc-chairman-rostin-behnam-to-step-down-in-february">CFTC Chairman Rostin Behnam To Step Down In February</a>
The bearish narrative isn't solely rooted in technical indicators. McCann also flagged a contraction in global liquidity, noting that &#8220;nearly $1 trillion in nominal terms&#8221; was drained last week alone. 
This tightening liquidity, compounded by a recent contraction in Tether's outstanding supply, adds to the uncertainty in the crypto market. 
&#8220;Tether's supply peaked the day after the FOMC crashed the markets,&#8221; McCann observed, marking a potential shift in sentiment.
On the macroeconomic front, McCann drew attention to the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/01/42754775/dollar-strength-to-be-driven-by-trumps-deregulation-tariff-and-tax-policies-in-2025-after-a-strong-2024">U.S. dollar's unexpected strength,</a> which he labeled a &#8220;problem for risk assets, especially Bitcoin.&#8221;
He elaborated on the peculiar market dynamics: &#8220;The $DXY actually moved up on a day the Fed cut interest rates&#8230;smashing through a multi-year resistance level that is now turning into support.&#8221;
What&#8217;s Next: Despite his current bearish stance, McCann remains optimistic about Bitcoin's long-term trajectory.
&#8220;Higher is my meme forever,&#8221; he said, suggesting that Bitcoin's upward march to new all-time highs would resume in due time. However, for now, he emphasized a tactical approach. &#8220;The easy money is over. It's time to be tactical, and for now, I'm tactically bearish.&#8221;
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/01/42854789/bitcoin-could-peak-by-late-march-arthur-hayes-says-heres-why">Bitcoin Could Peak By Late March, Arthur Hayes Says: Here&#8217;s Why</a></li>
</ul>
Image created using artificial intelligence with Midjourney.

Bitcoin Could Drop As Low As $75,000 If It Fills This Liquidity Gap, Expert Warns

Piper Sandler analyst Patrick Moley maintains CME Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>) with a Overweight and raises the price target from $250 to $258.

Piper Sandler Maintains Overweight on CME Gr, Raises Price Target to $258

In the preceding three months, 12 analysts have released ratings for CME Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>), presenting a wide array of perspectives from bullish to bearish.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">8</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $244.58, a high estimate of $260.00, and a low estimate of $226.00. Marking an increase of 4.37%, the current average surpasses the previous average price target of $234.33. 
<img src="https://www.benzinga.com/files/images/story/2025/1736190028_0.png" alt="price target chart" />
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
A clear picture of CME Gr's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Ashish Sabadra</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Sector Perform</td>
<td>$235.00</td>
<td>$235.00</td>
</tr>
<tr>
<td>Christopher Allen</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$250.00</td>
<td>$255.00</td>
</tr>
<tr>
<td>Kyle Voigt</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$260.00</td>
<td>$237.00</td>
</tr>
<tr>
<td>Benjamin Budish</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$257.00</td>
<td>$231.00</td>
</tr>
<tr>
<td>Brian Bedell</td>
<td>Deutsche Bank</td>
<td>Lowers</td>
<td>Hold</td>
<td>$226.00</td>
<td>$227.00</td>
</tr>
<tr>
<td>Patrick Moley</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Overweight</td>
<td>$250.00</td>
<td>$240.00</td>
</tr>
<tr>
<td>Ashish Sabadra</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Sector Perform</td>
<td>$235.00</td>
<td>$235.00</td>
</tr>
<tr>
<td>Owen Lau</td>
<td>Oppenheimer</td>
<td>Raises</td>
<td>Outperform</td>
<td>$258.00</td>
<td>$245.00</td>
</tr>
<tr>
<td>Christopher Allen</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$255.00</td>
<td>$250.00</td>
</tr>
<tr>
<td>Benjamin Budish</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$231.00</td>
<td>$219.00</td>
</tr>
<tr>
<td>Mike Cyprys</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$233.00</td>
<td>$210.00</td>
</tr>
<tr>
<td>Owen Lau</td>
<td>Oppenheimer</td>
<td>Raises</td>
<td>Outperform</td>
<td>$245.00</td>
<td>$228.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to CME Gr. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of CME Gr compared to the broader market.</li>
<li>Price Targets: Analysts predict movements in price targets, offering estimates for CME Gr's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of CME Gr's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/CME/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on CME Gr analyst ratings.</a>
<h2>All You Need to Know About CME Gr</h2>
Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies, energy, metals, and commodities. The Chicago Mercantile Exchange was founded in 1898 and in 2002 completed its IPO. Since then, CME Group has consolidated parts of the industry by merging with crosstown rival CBOT Holdings in 2007 before acquiring Nymex Holdings in 2008 and NEX in 2018. In addition, the company has a 27% stake in S&amp;P Dow Jones Indices, making the Chicago Mercantile Exchange the exclusive venue to trade and clear S&amp;P futures contracts. Through CME's acquisition of NEX, it also expanded into cash foreign exchange, fixed-income trading, and collateral optimization.
<h3>CME Gr: A Financial Overview</h3>
Market Capitalization Highlights: Above the industry average, the company's market capitalization signifies a significant scale, indicating strong confidence and market prominence.
Revenue Growth: CME Gr displayed positive results in 3 months. As of 30 September, 2024, the company achieved a solid revenue growth rate of approximately 18.43%. This indicates a notable increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Financials sector.
Net Margin: CME Gr's net margin is impressive, surpassing industry averages. With a net margin of 56.89%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): CME Gr's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of 3.23%, the company may face hurdles in achieving optimal financial performance.
Return on Assets (ROA): CME Gr's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of 0.69%, the company may face hurdles in achieving optimal financial performance.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.12.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

A Glimpse Into The Expert Outlook On CME Gr Through 12 Analysts

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Piper Sandler analyst Brent Bracelin downgraded the rating for ZoomInfo Technologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZI#NASDAQ">ZI</a>) from Neutral to Underweight and lowered the price target from $11 to $10. ZoomInfo shares closed at $10.64 on Friday. <a href="https://www.benzinga.com/quote/ZI/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Citigroup analyst Christopher Allen downgraded CME Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>) from Buy to Neutral and lowered the price target from $255 to $250. CME shares closed at $232.50 on Friday. <a href="https://www.benzinga.com/quote/CME/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>UBS analyst Brennan Hawken downgraded The Goldman Sachs Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GS#NYSE">GS</a>) from Buy to Neutral and announced a $610 price target. Goldman Sachs shares closed at $580.13 on Friday. <a href="https://www.benzinga.com/quote/GS/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Keybanc analyst Jeffrey Hammond downgraded Pentair plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PNR#NYSE">PNR</a>) from Overweight to Sector Weight and maintained the price target of $115. Pentair shares closed at $101.06 on Friday. <a href="https://www.benzinga.com/quote/PNR/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>RBC Capital analyst Jonathan Atkin downgraded the rating for T-Mobile US, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TMUS#NASDAQ">TMUS</a>) from Outperform to Sector Perform and lowered the price target from $255 to $240. T-Mobile US shares closed at $219.11 on Friday. <a href="https://www.benzinga.com/quote/TMUS/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying GS stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="555" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/06110323/image-23-1024x555.png" alt="" class="wp-image-720033" style="width:597px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/06110323/image-23-1024x555.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/06110323/image-23-300x163.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/06110323/image-23-768x416.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/06110323/image-23.png 1147w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/01/42816220/jim-cramer-likes-this-major-home-improvement-retailer-recommends-buying-it">Cramer: &#8216;At This Point,&#8217; SoundHound AI Rally &#8216;Is A Short Squeeze&#8217;</a></li>
</ul>

Downgrades

TMUS

This Goldman Sachs Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday

RBC Capital analyst Ashish Sabadra reiterates CME Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>) with a Sector Perform and maintains $235 price target.

Reiteration

RBC Capital Reiterates Sector Perform on CME Gr, Maintains $235 Price Target

Citigroup analyst Christopher Allen downgrades CME Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>) from Buy to Neutral and lowers the price target from $255 to $250.

Citigroup Downgrades CME Gr to Neutral, Lowers Price Target to $250

Q4 ADV reached&nbsp;25.5&nbsp;million contracts and December ADV reached 22.3&nbsp;million contracts.

CME Group Reports Average Daily Volume Of 26.5M Contracts During 2024, An Increase Of 9% Over 2023

William R Shepard, Director at CME Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>), disclosed an insider purchase on December 30, based on a new SEC filing.
What Happened: Shepard demonstrated confidence in CME Gr by purchasing 275 shares, as reported in a Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0001156375/000115637524000204//Archives/edgar/data/1156375/000115637524000204/0001156375-24-000204-index.htm">U.S. Securities and Exchange Commission</a> on Monday. The total value of the transaction is $64,282.
As of Tuesday morning, CME Gr shares are up by 0.05%, currently priced at $231.65.
<h3>Get to Know CME Gr Better</h3>
Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies, energy, metals, and commodities. The Chicago Mercantile Exchange was founded in 1898 and in 2002 completed its IPO. Since then, CME Group has consolidated parts of the industry by merging with crosstown rival CBOT Holdings in 2007 before acquiring Nymex Holdings in 2008 and NEX in 2018. In addition, the company has a 27% stake in S&amp;P Dow Jones Indices, making the Chicago Mercantile Exchange the exclusive venue to trade and clear S&amp;P futures contracts. Through CME's acquisition of NEX, it also expanded into cash foreign exchange, fixed-income trading, and collateral optimization.
<h3>CME Gr: A Financial Overview</h3>
Positive Revenue Trend: Examining CME Gr's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 18.43% as of 30 September, 2024, showcasing a substantial increase in top-line earnings. When compared to others in the Financials sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Exploring Profitability:
<ul>
<li>
Gross Margin: With a high gross margin of 86.19%, the company demonstrates effective cost control and strong profitability relative to its peers.
</li>
<li>
Earnings per Share (EPS): CME Gr's EPS is notably higher than the industry average. The company achieved a positive bottom-line trend with a current EPS of 2.51.
</li>
</ul>
Debt Management: CME Gr's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.12.
Valuation Metrics: A Closer Look
<ul>
<li>
Price to Earnings (P/E) Ratio: The current P/E ratio of 24.35 is below industry norms, indicating potential undervaluation and presenting an investment opportunity.
</li>
<li>
Price to Sales (P/S) Ratio: With a relatively high Price to Sales ratio of 13.78 as compared to the industry average, the stock might be considered overvalued based on sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): With an EV/EBITDA ratio lower than industry averages at 17.05, CME Gr could be considered undervalued.
</li>
</ul>
Market Capitalization Analysis: Above industry benchmarks, the company's market capitalization emphasizes a noteworthy size, indicative of a strong market presence.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Understanding the Significance of Insider Transactions</h3>
Insightful as they may be, insider transactions should be considered alongside a thorough examination of other investment criteria.
Considering the legal perspective, an "insider" is defined as any officer, director, or beneficial owner holding more than ten percent of a company's equity securities, according to Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and major hedge funds. These insiders are mandated to disclose their transactions through a Form 4 filing, to be submitted within two business days of the transaction.
Pointing towards optimism, a company insider's new purchase signals their positive anticipation for the stock to rise.
Nevertheless, insider sells may not necessarily indicate a bearish view and can be influenced by various factors.
<h3>Important Transaction Codes</h3>
In the domain of transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> frequently turn their focus to those taking place in the open market, as meticulously outlined in Table I of the Form 4 filing. A P in Box 3 indicates a purchase, while S signifies a sale. Transaction code C signals the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0001156375">Check Out The Full List Of CME Gr's Insider Trades.</a>
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22in8&amp;utm_source=benzinga-insights">Click here for access</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Insider Trades

CME Gr Director Trades $64K In Company Stock

Whales with a lot of money to spend have taken a noticeably bullish stance on CME Gr.
Looking at options history for CME Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>) we detected 21 trades.
If we consider the specifics of each trade, it is accurate to state that 33% of the investors opened trades with bullish expectations and 19% with bearish.
From the overall spotted trades, 11 are puts, for a total amount of $2,422,975 and 10, calls, for a total amount of $602,430.
<h3>What's The Price Target?</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $85.0 to $300.0 for CME Gr over the last 3 months. 
<h3>Volume &amp; Open Interest Development</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for CME Gr's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of CME Gr's whale activity within a strike price range from $85.0 to $300.0 in the last 30 days. 
<h3>CME Gr Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1735245035_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>CME</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/17/25</td>
<td>$68.4</td>
<td>$65.0</td>
<td>$66.5</td>
<td>$300.00</td>
<td>$1.9M</td>
<td align="right">0</td>
<td align="right">300</td>
</tr>
<tr>
<td>CME</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$154.1</td>
<td>$152.5</td>
<td>$154.1</td>
<td>$85.00</td>
<td>$154.1K</td>
<td align="right">5</td>
<td align="right">30</td>
</tr>
<tr>
<td>CME</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$16.8</td>
<td>$16.4</td>
<td>$16.55</td>
<td>$250.00</td>
<td>$87.7K</td>
<td align="right">7</td>
<td align="right">81</td>
</tr>
<tr>
<td>CME</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$139.1</td>
<td>$137.7</td>
<td>$139.1</td>
<td>$100.00</td>
<td>$69.5K</td>
<td align="right">3</td>
<td align="right">30</td>
</tr>
<tr>
<td>CME</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/17/25</td>
<td>$140.3</td>
<td>$137.7</td>
<td>$139.1</td>
<td>$100.00</td>
<td>$69.5K</td>
<td align="right">3</td>
<td align="right">25</td>
</tr>
</tbody>
</table>

<h3>About CME Gr</h3>
Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies, energy, metals, and commodities. The Chicago Mercantile Exchange was founded in 1898 and in 2002 completed its IPO. Since then, CME Group has consolidated parts of the industry by merging with crosstown rival CBOT Holdings in 2007 before acquiring Nymex Holdings in 2008 and NEX in 2018. In addition, the company has a 27% stake in S&amp;P Dow Jones Indices, making the Chicago Mercantile Exchange the exclusive venue to trade and clear S&amp;P futures contracts. Through CME's acquisition of NEX, it also expanded into cash foreign exchange, fixed-income trading, and collateral optimization.
Having examined the options trading patterns of CME Gr, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Where Is CME Gr Standing Right Now?</h3>
<ul>
<li>With a volume of 514,277, the price of CME is down -0.14% at $239.13. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 48 days.</li>
</ul>
<h3>Professional Analyst Ratings for CME Gr</h3>
A total of 2 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $258.5.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Barclays persists with their Equal-Weight rating on CME Gr, maintaining a target price of $257. 
&#x2A; An analyst from Keefe, Bruyette &amp; Woods persists with their Market Perform rating on CME Gr, maintaining a target price of $260. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for CME Gr, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

Options

What the Options Market Tells Us About CME Gr

Keefe, Bruyette &amp; Woods analyst Kyle Voigt maintains CME Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>) with a Market Perform and raises the price target from $237 to $260.

Keefe, Bruyette & Woods Maintains Market Perform on CME Gr, Raises Price Target to $260

This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Traders often look for circumstances when the market estimation of an option diverges away from its normal worth. Abnormal amounts of trading activity could push option prices to hyperbolic or underperforming levels. 
Below are some instances of options activity happening in the Financials sector: 
<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>LPLA</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$340.00</td>
<td>$116.2K</td>
<td>89</td>
<td>1.7K</td>
</tr>
<tr>
<td>SOFI</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$15.00</td>
<td>$54.9K</td>
<td>57.0K</td>
<td>1.1K</td>
</tr>
<tr>
<td>KKR</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>12/20/24</td>
<td>$155.00</td>
<td>$25.8K</td>
<td>2.9K</td>
<td>311</td>
</tr>
<tr>
<td>BLK</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$1060.00</td>
<td>$35.8K</td>
<td>774</td>
<td>279</td>
</tr>
<tr>
<td>JPM</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$250.00</td>
<td>$51.5K</td>
<td>956</td>
<td>112</td>
</tr>
<tr>
<td>CME</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$210.00</td>
<td>$26.6K</td>
<td>358</td>
<td>106</td>
</tr>
<tr>
<td>PYPL</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>06/18/26</td>
<td>$72.50</td>
<td>$50.8K</td>
<td>214</td>
<td>100</td>
</tr>
<tr>
<td>HOOD</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>08/15/25</td>
<td>$40.00</td>
<td>$52.7K</td>
<td>2.4K</td>
<td>52</td>
</tr>
<tr>
<td>V</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$250.00</td>
<td>$82.1K</td>
<td>41</td>
<td>22</td>
</tr>
<tr>
<td>GS</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$600.00</td>
<td>$31.3K</td>
<td>531</td>
<td>17</td>
</tr>
</tbody>
</table>

<h2>Explanation</h2>
These itemized elaborations have been created using the accompanying table. 
• For LPLA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LPLA#NASDAQ">LPLA</a>), we notice a call option trade that happens to be bearish, expiring in 3 day(s) on December 20, 2024. This event was a transfer of 750 contract(s) at a $340.00 strike. The total cost received by the writing party (or parties) was $116.2K, with a price of $155.0 per contract. There were 89 open contracts at this strike prior to today, and today 1780 contract(s) were bought and sold. 
• For SOFI (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOFI#NASDAQ">SOFI</a>), we notice a call option sweep that happens to be bullish, expiring in 395 day(s) on January 16, 2026. This event was a transfer of 100 contract(s) at a $15.00 strike. This particular call needed to be split into 3 different trades to become filled. The total cost received by the writing party (or parties) was $54.9K, with a price of $549.0 per contract. There were 57034 open contracts at this strike prior to today, and today 1163 contract(s) were bought and sold. 
• Regarding KKR (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KKR#NYSE">KKR</a>), we observe a put option sweep with neutral sentiment. It expires in 3 day(s) on December 20, 2024. Parties traded 63 contract(s) at a $155.00 strike. This particular put needed to be split into 4 different trades to become filled. The total cost received by the writing party (or parties) was $25.8K, with a price of $411.0 per contract. There were 2947 open contracts at this strike prior to today, and today 311 contract(s) were bought and sold. 
• For BLK (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLK#NYSE">BLK</a>), we notice a call option trade that happens to be bearish, expiring in 94 day(s) on March 21, 2025. This event was a transfer of 8 contract(s) at a $1060.00 strike. The total cost received by the writing party (or parties) was $35.8K, with a price of $4480.0 per contract. There were 774 open contracts at this strike prior to today, and today 279 contract(s) were bought and sold. 
• Regarding JPM (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JPM#NYSE">JPM</a>), we observe a put option sweep with bearish sentiment. It expires in 31 day(s) on January 17, 2025. Parties traded 34 contract(s) at a $250.00 strike. This particular put needed to be split into 17 different trades to become filled. The total cost received by the writing party (or parties) was $51.5K, with a price of $1515.0 per contract. There were 956 open contracts at this strike prior to today, and today 112 contract(s) were bought and sold. 
• Regarding CME (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>), we observe a put option sweep with bullish sentiment. It expires in 94 day(s) on March 21, 2025. Parties traded 106 contract(s) at a $210.00 strike. This particular put needed to be split into 20 different trades to become filled. The total cost received by the writing party (or parties) was $26.6K, with a price of $250.0 per contract. There were 358 open contracts at this strike prior to today, and today 106 contract(s) were bought and sold. 
• For PYPL (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PYPL#NASDAQ">PYPL</a>), we notice a put option sweep that happens to be neutral, expiring in 548 day(s) on June 18, 2026. This event was a transfer of 80 contract(s) at a $72.50 strike. This particular put needed to be split into 14 different trades to become filled. The total cost received by the writing party (or parties) was $50.8K, with a price of $635.0 per contract. There were 214 open contracts at this strike prior to today, and today 100 contract(s) were bought and sold. 
• For HOOD (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOOD#NASDAQ">HOOD</a>), we notice a call option trade that happens to be bearish, expiring in 241 day(s) on August 15, 2025. This event was a transfer of 50 contract(s) at a $40.00 strike. The total cost received by the writing party (or parties) was $52.7K, with a price of $1054.0 per contract. There were 2402 open contracts at this strike prior to today, and today 52 contract(s) were bought and sold. 
• Regarding V (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/V#NYSE">V</a>), we observe a call option trade with bullish sentiment. It expires in 185 day(s) on June 20, 2025. Parties traded 11 contract(s) at a $250.00 strike. The total cost received by the writing party (or parties) was $82.1K, with a price of $7465.0 per contract. There were 41 open contracts at this strike prior to today, and today 22 contract(s) were bought and sold. 
• For GS (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GS#NYSE">GS</a>), we notice a put option trade that happens to be bearish, expiring in 31 day(s) on January 17, 2025. This event was a transfer of 10 contract(s) at a $600.00 strike. The total cost received by the writing party (or parties) was $31.3K, with a price of $3130.0 per contract. There were 531 open contracts at this strike prior to today, and today 17 contract(s) were bought and sold. 
Options Alert Terminology 
 - Call Contracts: The right to buy shares as indicated in the contract. 
 - Put Contracts: The right to sell shares as indicated in the contract. 
 - Expiration Date: When the contract expires. One must act on the contract by this date if one wants to use it. 
 - Premium/Option Price: The price of the contract. 
For more information, visit our <a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">Guide to Understanding Options Alerts</a> or read <a href="https://www.benzinga.com/markets/options">more about unusual options activity</a>. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

LPLA

PYPL

SOFI

10 Financials Stocks With Whale Alerts In Today's Session

CME Gr's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CME#NYSE">CME</a>) short percent of float has risen 28.3% since its last report. The company recently reported that it has 4.90 million shares sold short, which is 1.36% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.28 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>CME Gr Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1734367517_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for CME Gr has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing CME Gr's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, CME Gr's peer group average for short interest as a percentage of float is 3.72%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Looking Into CME Gr's Recent Short Interest

In the preceding three months, 18 analysts have released ratings for CME Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>), presenting a wide array of perspectives from bullish to bearish.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">4</td>
<td align="right">10</td>
<td align="right">1</td>
<td align="right">1</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">5</td>
<td align="right">1</td>
<td align="right">1</td>
</tr>
</tbody>
</table>
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $234.0, a high estimate of $258.00, and a low estimate of $180.00. This upward trend is apparent, with the current average reflecting a 4.28% increase from the previous average price target of $224.40.
<img src="https://www.benzinga.com/files/images/story/2024/1733767216_0.png" alt="price target chart" />
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
The analysis of recent analyst actions sheds light on the perception of CME Gr by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Benjamin Budish</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$257.00</td>
<td>$231.00</td>
</tr>
<tr>
<td>Brian Bedell</td>
<td>Deutsche Bank</td>
<td>Lowers</td>
<td>Hold</td>
<td>$226.00</td>
<td>$227.00</td>
</tr>
<tr>
<td>Patrick Moley</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Overweight</td>
<td>$250.00</td>
<td>$240.00</td>
</tr>
<tr>
<td>Ashish Sabadra</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Sector Perform</td>
<td>$235.00</td>
<td>$235.00</td>
</tr>
<tr>
<td>Owen Lau</td>
<td>Oppenheimer</td>
<td>Raises</td>
<td>Outperform</td>
<td>$258.00</td>
<td>$245.00</td>
</tr>
<tr>
<td>Christopher Allen</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$255.00</td>
<td>$250.00</td>
</tr>
<tr>
<td>Benjamin Budish</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$231.00</td>
<td>$219.00</td>
</tr>
<tr>
<td>Mike Cyprys</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$233.00</td>
<td>$210.00</td>
</tr>
<tr>
<td>Owen Lau</td>
<td>Oppenheimer</td>
<td>Raises</td>
<td>Outperform</td>
<td>$245.00</td>
<td>$228.00</td>
</tr>
<tr>
<td>Simon Clinch</td>
<td>Redburn Atlantic</td>
<td>Announces</td>
<td>Neutral</td>
<td>$244.00</td>
<td>-</td>
</tr>
<tr>
<td>Patrick Moley</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Overweight</td>
<td>$240.00</td>
<td>$225.00</td>
</tr>
<tr>
<td>Benjamin Budish</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$219.00</td>
<td>$209.00</td>
</tr>
<tr>
<td>Christopher Allen</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$250.00</td>
<td>$240.00</td>
</tr>
<tr>
<td>Alexander Blostein</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Sell</td>
<td>$198.00</td>
<td>$195.00</td>
</tr>
<tr>
<td>Ashish Sabadra</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Sector Perform</td>
<td>$235.00</td>
<td>$235.00</td>
</tr>
<tr>
<td>Craig Siegenthaler</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Underperform</td>
<td>$180.00</td>
<td>$177.00</td>
</tr>
<tr>
<td>Ashish Sabadra</td>
<td>RBC Capital</td>
<td>Announces</td>
<td>Sector Perform</td>
<td>$235.00</td>
<td>-</td>
</tr>
<tr>
<td>Bill Katz</td>
<td>TD Cowen</td>
<td>Announces</td>
<td>Hold</td>
<td>$221.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to CME Gr. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of CME Gr compared to the broader market.</li>
<li>Price Targets: Understanding forecasts, analysts offer estimates for CME Gr's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of CME Gr's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/CME/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on CME Gr analyst ratings.</a>
<h2>Discovering CME Gr: A Closer Look</h2>
Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies, energy, metals, and commodities. The Chicago Mercantile Exchange was founded in 1898 and in 2002 completed its IPO. Since then, CME Group has consolidated parts of the industry by merging with crosstown rival CBOT Holdings in 2007 before acquiring Nymex Holdings in 2008 and NEX in 2018. In addition, the company has a 27% stake in S&amp;P Dow Jones Indices, making the Chicago Mercantile Exchange the exclusive venue to trade and clear S&amp;P futures contracts. Through CME's acquisition of NEX, it also expanded into cash foreign exchange, fixed-income trading, and collateral optimization.
<h3>CME Gr's Economic Impact: An Analysis</h3>
Market Capitalization Highlights: Above the industry average, the company's market capitalization signifies a significant scale, indicating strong confidence and market prominence.
Revenue Growth: CME Gr's remarkable performance in 3 months is evident. As of 30 September, 2024, the company achieved an impressive revenue growth rate of 18.43%. This signifies a substantial increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Financials sector.
Net Margin: CME Gr's net margin is impressive, surpassing industry averages. With a net margin of 56.89%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): CME Gr's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of 3.23%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): CME Gr's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of 0.69%, the company may face hurdles in achieving optimal financial returns.
Debt Management: CME Gr's debt-to-equity ratio is below the industry average at 0.12, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>Analyst Ratings: What Are They?</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

The Latest Analyst Ratings For CME Gr

Barclays analyst Benjamin Budish maintains CME Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>) with a Equal-Weight and raises the price target from $231 to $257.

Barclays Maintains Equal-Weight on CME Gr, Raises Price Target to $257

CME Group (CME) announced that its international average daily volume, or ADV, reached a record 7.8M contracts in 2024, up 14% from 2023. Reflectin...

CME Group reports FY24 international ADV 7.8M contracts, up 14%

Mawer Investment Management Q4 2024 Quarterly Update

Companies in the Financial sector have received a lot of coverage today as analysts weigh in on Webster Financial (WBS – Research Report), CME Grou...

Analysts Conflicted on These Financial Names: Webster Financial (WBS), CME Group (CME) and UBS Group AG (UBS)

Cboe Global: Growth Catalysts, But Overpriced Entry

CME Group (CME) announced it will introduce options on Bitcoin ($BTC) Friday futures on February 24, pending regulatory review. "These new contract...

CME Group to introduce options on Bitcoin Friday futures

CME Group to launch options on bitcoin Friday futures

'No-Brainer' Buys: If I Could Only Own 2 Dividend Stocks

Bitcoin to fall W/W as White House confirms Trump's tariff plans

'Incredible demand for physical gold' adding to already tight market, analyst says

5 Relatively Secure And Cheap Dividend Stocks, Yields Upto 8% (February 2025)

AAAU

ARCC

ASHTF

ASHTY

ASMIY

ASML

ASMLF

ASMXF

AVGO

AZNCF

BZLFF

BZLFY

CBOE

CCDBF

CCLLF

CMPGF

CMPGY

COIN

CTAS

CTSDF

FINGF

GDXJ

GLDM

IAFNF

ICLR

MCHP

MPLX

MSTR

NDAQ

NONOF

NUGT

ODFL

OUNZ

PHYS

PSLV

RING

RIOT

SGOL

SILJ

SIVR

STLJF

TMTNF

TROLB

TRRVF

TSMWF

WOLTF

WTKWY

ZION

ZURVY

Screenshot 2024-12-12 at 6.46.22 PM

Commodities

Some Anticipate A Bear Market In 2025, But Geopolitical Conflicts May Continue To Drive Gold Prices Higher – Time To Buy A Gold IRA?

Screenshot 2024-05-07 at 5.26.30 PM

With The Cryptocurrency Market Historically Tumultuous, Regulated Futures Brokers Like EdgeClear May Offer More Security Than Their Spot Counterparts

Press Releases

CME Group Announces Trading Hours for U.S. National Day of Mourning to Honor Former President Jimmy Carter

CME Group Reports Record Annual ADV of 26.5 Million Contracts in 2024, Driven by Growth Across All Six Asset Classes

CME Group Inc. Announces Fourth-Quarter and Year-End 2024 Earnings Release, Conference Call

Farmer sentiment drifts lower while producers remain optimistic about the future

Offerings

CME Group to Launch Hard Red Spring Wheat Futures and Options

Fintech

CME Group International Average Daily Volume Reaches Record 7.8 Million Contracts in 2024, Up 14% from 2023

Contracts

CME Group Futures to Launch on Robinhood, Bringing New Trading Opportunities to Retail Investors

Comments

CME Gr

ニュース

最新ニュース CME Gr (NASDAQ:CME) 株価情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル